LEVOLOPE SYRUP

Product Description

LEVOLOPE SYRUP | Levocloperastine Fendizoate 20mg/5ml Syrup & Lenvatinib 4mg Capsule

Elevate your pharmaceutical portfolio with LEVOLOPE SYRUP, a premium-quality respiratory formulation featuring Levocloperastine Fendizoate 20mg/5ml a potent antitussive agent designed to provide effective relief from persistent coughs. Paired with Lenvatinib 4mg Capsules, this combination addresses a diverse range of clinical needs, making it a versatile addition for distributors, retailers, and bulk buyers.

Key Benefits:

• Powerful Antitussive Action: Levocloperastine Fendizoate targets the cough reflex centrally without causing sedation, ensuring patient comfort.

• Broad Therapeutic Usage: Suitable for managing dry coughs in adults and pediatric patients with minimal side effects.

• High-Quality Manufacturing: Produced under stringent GMP standards, ensuring consistent efficacy and safety.

• Complementary Oncology Support: Lenvatinib 4mg Capsules serve as a valuable treatment for certain cancers, enhancing product range appeal.

• Bulk Supply Ready: Ideal for pharmaceutical wholesalers and medical distributors seeking reliable stock with attractive margins.

Usage:

• LEVOLOPE SYRUP: Administer as prescribed by physicians for symptomatic relief of cough.

• Lenvatinib Capsules: Used under oncologist supervision as targeted therapy.